• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic’s Infuse bone growth product may increase male infertility

Medtronic’s Infuse bone growth product may increase male infertility

May 25, 2011 By MassDevice staff

company

There’s more bad news for Medtronic Inc.’s (NYSE:MDT) Infuse product after a report that the bio-engineered bone growth protein can increase the risk of infertility in men, according to a study published in the June issue of The Spine Journal.

Of 69 patients treated with the Infuse product, which has been widely used to fuse spinal vertebrae during surgeries since 2002, 7.2 percent developed retrograde ejaculation compared to 0.6 percent of those who didn’t receive Infuse, according to the Stanford University School of Medicine study.

Among 69 male patients treated with Infuse during surgery, five developed retrograde ejaculation compared to one case among 174 men who received a bone graft. The condition leads to temporary or permanent sterility in men.

The Infuse product, already mired in the U.S. Dept. of Justice’s probe of alleged off-label marketing of Medtronic’s bone growth product line, brought in $900 million for MDT in its most recent fiscal year.

The most recent findings regarding male infertility are in stark contrast to earlier research funded by MDT, the New York Times reports. The Infuse label notes sterility-related complications, but attributes them to surgical technique rather than to the product.

The bone growth product line has been problematic for Medtronic this year, beginning when the company was sued by its employees over allegations that the Fridley, Minn.-based company kept them in the dark about problems related to its Infuse bone graft material.

In March the U.S. Food & Drug Administration put the kaibosh on MDT’s Amplify spine device, which was designed to address concerns about off-label use of the Infuse device.

Filed Under: News Well, Spine Tagged With: Orthobiologics

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy